Objective: The goal of this study was to evaluate the number and frequency of adverse effects in a population of clinical canine patients receiving Nexterone.

Animals: Seventeen canine patients receiving Nexterone (five of which were treated during cardiopulmonary arrest).

Methods: An electronic records search for canine patients receiving intravenous Nexterone at the Michigan State University Veterinary Teaching Hospital was performed and retrospectively evaluated for patient demographic information, pre- and post-treatment values for heart rate, blood pressure and rhythm diagnosis, as well as any documented adverse effects (hypotension, anaphylaxis, vomiting, phlebitis, and death). Data including the underlying cardiac or systemic disease, concurrent medications, as well as the final clinical diagnosis and treatment outcome were also recorded.

Results: No adverse effects were noted in this population of clinical canine patients receiving Nexterone. The median pre-treatment heart rate and blood pressure values were 160 bpm (range 120-300 bpm) and 105 mmHg (range 60-170 mmHg), respectively. After treatment, the median heart rate was significantly lower (120 bpm; range 68-172 bpm). The median blood pressure similar to the pre-treatment blood pressure (115 mmHg; range 100-150 mmHg).

Conclusion: In this study of 17 dogs receiving the premixed formulation of injectable Nexterone, no dogs were found to have acute adverse side effects. Nexterone appears to be a safe drug choice for in-hospital treatment of canine arrhythmias. Further studies are needed to assess the efficacy and long-term effects of this medication and the ideal dosing protocol for various arrhythmias.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvc.2015.10.009DOI Listing

Publication Analysis

Top Keywords

adverse effects
16
canine patients
16
patients receiving
16
blood pressure
16
heart rate
12
effects population
8
population clinical
8
clinical canine
8
receiving nexterone
8
rate blood
8

Similar Publications

Background: Billions of dollars have been spent implementing regulations to reduce traffic-related air pollution (TRAP) from exhaust pipe emissions. However, few health studies have evaluated the change in TRAP emissions and associations with infant health outcomes. We hypothesize that the magnitude of association between vehicle exposure measures and adverse birth outcomes has decreased over time, parallelling regulatory improvements in exhaust pipe emissions.

View Article and Find Full Text PDF

Background: Dialysis patients have high rates of fracture morbidity, but evidence on optimal management strategies for osteoporosis is scarce.

Objective: To determine the risk for cardiovascular events and fracture prevention effects with denosumab compared with oral bisphosphonates in dialysis-dependent patients.

Design: An observational study that attempts to emulate a target trial.

View Article and Find Full Text PDF

Group B (GBS) is a major cause of fetal and neonatal mortality worldwide. Many of the adverse effects of invasive GBS are associated with inflammation; therefore, understanding bacterial factors that promote inflammation is of critical importance. Membrane vesicles (MVs), which are produced by many bacteria, may modulate host inflammatory responses.

View Article and Find Full Text PDF

Infant neonatal intensive care unit (NICU) hospitalization increases maternal risk for post-traumatic stress disorder (PTSD) symptoms, which may negatively impact mother-child attachment and infant growth and development. Prior studies have documented positive associations between unmet parenting expectations and adverse maternal psychological outcomes, including post-NICU discharge. However, no studies have yet explored how unmet parenting expectations may be associated with maternal NICU-related PTSD symptoms.

View Article and Find Full Text PDF

Short-term disuse leads to rapid declines in muscle mass and strength. These declines are driven by changes at all levels of the neuromuscular system; the brain, spinal cord and skeletal muscle. In addition to neural input from the central and peripheral nervous systems to the muscle, molecular factors originating in the muscle can be transported to the central nervous system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!